RxDoctor Payments Data

Freddie Williams, MD

Cardiovascular Disease · Kingsport, TNNPI 1356553648

Payments from drug & device makers

$2,338in general payments, 2019–2025

Across 54 payments — averaging $43.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$1K
  • Heartflow, Inc.$531
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$246
  • E.r. Squibb & Sons, L.L.C.$172
  • GE HealthCare$113
  • Novartis$49
  • plus $95 from 5 others

What the payments were for

  • Travel & lodging$1,17450%
  • Food & beverage$1,15149%
  • Education$141%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,338 in reported general payments places this provider in the 50th percentile of 429 cardiovascular disease providers in Tennessee.

See all cardiovascular disease providers in Tennessee

Medicare billing

Part B allowed, 2024
$147,966
Medicare patients
991
Services billed
1,840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban398$348,965
EntrestoSacubitril/Valsartan92$88,465
XareltoRivaroxaban57$62,058
FarxigaDapagliflozin Propanediol31$31,526
BrilintaTicagrelor47$23,439
JardianceEmpagliflozin22$21,154
VascepaIcosapent Ethyl11$7,279
Diltiazem 24hr Er (Cd)Diltiazem Hcl77$2,942
Ranolazine ErRanolazine29$2,778
Metoprolol Succinate247$2,495
Isosorbide Mononitrate ErIsosorbide Mononitrate175$2,050
Carvedilol175$1,972
Rosuvastatin Calcium150$1,924
Atorvastatin Calcium169$1,663
Potassium Chloride69$1,088

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$31$348,965398 claims
NovartisEntresto$49$88,46592 claims
Johnson & JohnsonXarelto$14$62,05857 claims
AstraZenecaFarxiga, Brilinta$14$54,96578 claims
Boehringer IngelheimJardiance$17$21,15422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 429 cardiovascular disease providers in Tennessee.

Other cardiovascular disease in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →